X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 91 filers reported holding X4 PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,592,702 | -39.8% | 2,378,626 | +7.2% | 0.00% | – |
| Q2 2023 | $4,305,991 | +2800.6% | 2,219,583 | +1200.8% | 0.00% | – |
| Q1 2023 | $148,451 | -56.2% | 170,633 | -50.0% | 0.00% | – |
| Q4 2022 | $338,878 | +260.5% | 341,266 | +523.5% | 0.00% | – |
| Q3 2022 | $94,000 | +77.4% | 54,733 | 0.0% | 0.00% | – |
| Q2 2022 | $53,000 | -44.8% | 54,733 | 0.0% | 0.00% | – |
| Q1 2022 | $96,000 | -13.5% | 54,733 | +12.9% | 0.00% | – |
| Q4 2021 | $111,000 | -56.6% | 48,480 | 0.0% | 0.00% | – |
| Q3 2021 | $256,000 | -18.7% | 48,480 | 0.0% | 0.00% | – |
| Q2 2021 | $315,000 | -86.8% | 48,480 | -82.5% | 0.00% | – |
| Q1 2021 | $2,384,000 | -9.6% | 276,840 | -32.5% | 0.00% | – |
| Q4 2020 | $2,636,000 | -8.0% | 409,910 | -3.1% | 0.00% | – |
| Q3 2020 | $2,864,000 | -26.9% | 423,086 | +0.7% | 0.00% | – |
| Q2 2020 | $3,917,000 | +42.4% | 420,286 | +52.9% | 0.00% | – |
| Q1 2020 | $2,750,000 | +47.1% | 274,955 | +57.4% | 0.00% | – |
| Q4 2019 | $1,869,000 | +3.5% | 174,664 | +23.0% | 0.00% | – |
| Q3 2019 | $1,805,000 | +48.7% | 142,007 | +75.5% | 0.00% | – |
| Q2 2019 | $1,214,000 | +294.2% | 80,926 | +357.4% | 0.00% | – |
| Q1 2019 | $308,000 | – | 17,692 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 311,492 | $2,682,000 | 3.48% |
| Sio Capital Management, LLC | 804,597 | $6,928,000 | 1.41% |
| Bain Capital Life Sciences Investors, LLC | 2,119,540 | $18,249,000 | 1.03% |
| SV Health Investors, LLC | 311,490 | $2,682,000 | 1.00% |
| Monashee Investment Management LLC | 574,712 | $4,948,000 | 0.76% |
| Ikarian Capital, LLC | 2,614,988 | $22,515,000 | 0.76% |
| Abingworth LLP | 229,885 | $1,956,000 | 0.68% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $2,884,000 | 0.67% |
| BVF INC/IL | 1,091,579 | $9,398,000 | 0.35% |
| Endurant Capital Management LP | 151,996 | $1,309,000 | 0.34% |